MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_CAR-T (Chimeric Antigen Receptors-T Cell), T Cell Engager (TCE) & T-Cell Research
Affini-T Therapeutics
Organization & Developments: Affini-T Therapeutics
Parents
Affini-T Therapeutics
Children
*Developing T-cell receptors against targets like KRAs and p53 that are fundamental to tumor biology and leveraging synthetic biology to treat pancreatic, colorectal, and lung cancers.
2025: Precision immunotherapy targeting oncogenic driver mutations therapies for patients with solid tumors
Jumps
Finance & Acquisition: Affini-T Therapeutics
Key People: Affini-T Therapeutics